LinaTech Debuts at LEAP East | Sharing the Global Development Path of Domestic Radiotherapy Equipment

From July 8 to 10, LEAP, one of the world’s top tech events, made its debut in the Asia-Pacific region with LEAP East 2026 held in Hong Kong. Co-hosted by Saudi Arabia’s Tahaluf, MCIT and SAFCSP, the event serves as a bridge for sci-tech innovation cooperation between Asia and the Middle East. Dr. Jonathan Yao, Chairman of LinaTech, was invited to the LEAP East Biotechnology Forum to discuss pathways for the global development of domestic medical devices.

Over the past two decades, China’s medical device industry has achieved leapfrog development. Core upstream materials have continuously broken overseas monopolies to support the global biomedicine industry; high-end equipment such as cancer treatment systems have joined the world’s first tier; original minimally invasive technologies are continuously exported overseas, gradually establishing new clinical standards. Nevertheless, global expansion of the industry still faces multiple practical obstacles, including tightening global regulatory rules, volatile geopolitical trade environments and insufficient overseas localized operation capabilities. At the same time, normalized centralized procurement in China and intensifying industry competition mean overseas expansion has evolved from an optional corporate strategy to an inevitable requirement for the whole industry.

Drawing on years of hands-on global expansion experience, Dr. Jonathan Yao shared insights into global markets at the forum. Emerging markets represented by Africa, South America and Central Asia have growing demand for cancer diagnosis and treatment, yet radiotherapy equipment penetration remains far lower than Europe and the United States, presenting substantial market gaps. Domestic medical devices feature high cost-performance, efficient diagnosis and treatment, and fully independent supply chains free from external restrictions, which well match the demands of local medical institutions. Coupled with policy dividends from Belt and Road industrial cooperation, they boast broad growth potential.
Riding on Hong Kong’s initiative to support mainland enterprises “going global together”, LinaTech will continue improving its global localized service and clinical training system, steadily advancing overseas registration and certification for multiple innovative radiotherapy devices. Relying on international sci-tech platforms such as LEAP East, LinaTech will further expand overseas markets in Asia and the Middle East, delivering China’s high-end medical solutions worldwide with fully self-developed domestic radiotherapy technologies.
Recommended Reading
Hotline:+86 10 67888916
Time:8:00 - 18:00